Arcturus Therapeutics Holdings Inc. (ARCT) Social Stream
ARCTURUS THERAPEUTICS HOLDINGS INC (ARCT) Price Targets From Analysts
Use the tables below to see what analysts covering ARCTURUS THERAPEUTICS HOLDINGS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 11 | $140 | $25 | $73.3 | $13.05 | 461.69% |
| 2021-11-16 | 10 | $140 | $27 | $78 | $13.05 | 497.7% |
| 2022-01-03 | 9 | $140 | $31 | $84.375 | $13.05 | 546.55% |
| 2022-01-24 | 8 | $140 | $31 | $79.571 | $13.05 | 509.74% |
| 2022-01-26 | 8 | $140 | $31 | $76.428 | $13.05 | 485.66% |
| 2022-02-28 | 8 | $140 | $31 | $76.428 | $13.05 | 485.66% |
| 2022-03-01 | 8 | $140 | $31 | $75.428 | $13.05 | 477.99% |
| 2022-04-20 | 8 | $140 | $25 | $74.285 | $13.05 | 469.23% |
| 2022-04-21 | 8 | $140 | $25 | $62.142 | $13.05 | 376.18% |
| 2022-05-09 | 8 | $140 | $25 | $58.166 | $13.05 | 345.72% |
| 2022-05-11 | 8 | $140 | $18 | $59.428 | $13.05 | 355.39% |
| 2022-05-24 | 9 | $140 | $8 | $47.444 | $13.05 | 263.56% |
| 2022-07-19 | 8 | $140 | $8 | $42.222 | $13.05 | 223.54% |
| 2022-08-10 | 10 | $140 | $8 | $47.7 | $13.05 | 265.52% |
The Trend in the Analyst Price Target
ARCT's average price target has moved down $33.28 over the prior 13 months.
Over the past 39 weeks, ARCT's average upside potential has been 178.45%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 11 | 140 | 27 | 73.900 | 36.23 | 103.97% |
| 2021-11-09 | 10 | 140 | 27 | 77.111 | 36.23 | 112.84% |
| 2022-02-14 | 8 | 140 | 31 | 76.428 | 23.25 | 228.72% |
| 2022-03-01 | 8 | 140 | 25 | 74.285 | 22.08 | 236.44% |
| 2022-05-11 | 8 | 140 | 17 | 52.375 | 13.04 | 301.65% |
ARCT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.8 | 4 | 0 | 3 | 3 | 3 | 10 |
The Trend in the Broker Recommendations
Over the past 153 days, ARCT's average broker recommendation rating worsened by 0.3.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, ARCTURUS THERAPEUTICS HOLDINGS INC's variance in analysts' estimates is lower than -1850.49% of them.
- ARCTURUS THERAPEUTICS HOLDINGS INC's number of analysts covering the stock is greater than 1897.87% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ARCTURUS THERAPEUTICS HOLDINGS INC's average analyst price target is higher than 1861.28% of them.
- In the context of stocks in the small market cap category, ARCTURUS THERAPEUTICS HOLDINGS INC's upside potential (average analyst target price relative to current price) is higher than 1467.37% of them.
Stocks similar to ARCTURUS THERAPEUTICS HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ARAV, AQST, and APTX.
View All Top Stocks by Price Target
Is ARCT a Buy, Hold or Sell? See the POWR Ratings now!